Protect your idea before you share it

This Non-Disclosure Agreement ("Agreement") is executed on the 30th day of October, 2026.

BETWEEN MYCrave Consultancy & Services, a consultancy firm engaged in Intellectual Property Rights (IPR), Patent Drafting, Research & Development, Technology Commercialization, Design Registration, Copyright, Trademark, Business Consulting and Innovation Management, having its registered office at FF-120, Atmiya complex, near maneja crossing Vadodara, Gujarat 390013 (hereinafter referred to as "MYCrave", which expression shall unless repugnant to the context include its successors, affiliates, representatives, employees and permitted assigns),

AND [Client name], of [address] (hereinafter referred to as the "Disclosing Party" or "Client", which expression shall include his/her/its successors and permitted assigns). MYCrave and the Client are individually referred to as a "Party" and collectively as the "Parties."

1. Purpose. The Client intends to disclose confidential, proprietary and/or patentable information to MYCrave for the purpose of evaluating, researching, drafting, protecting, prosecuting, commercializing, licensing, developing, filing, reviewing, or otherwise providing Intellectual Property and Innovation-related services. MYCrave agrees to receive such information solely for the above purpose and to maintain its confidentiality in accordance with the terms of this Agreement.
2. Confidential Information. For the purposes of this Agreement, the expression "Confidential Information" shall mean and include every form of information disclosed by the Client to MYCrave, whether before or after the execution of this Agreement, irrespective of whether such disclosure is made orally, visually, electronically, digitally, physically or in writing. Such Confidential Information shall include, without limitation, inventions, novel ideas, research concepts, patentable subject matter, utility models, industrial designs, engineering drawings, sketches, technical specifications, formulations, manufacturing methods, process parameters, algorithms, software, source code, object code, databases, artificial intelligence models, machine learning models, datasets, laboratory records, experimental observations, scientific analyses, feasibility studies, business methods, commercialization strategies, prototypes, product concepts, financial information, customer information, marketing strategies, unpublished patent applications, technical reports, presentations, photographs, videos, samples, know-how, trade secrets and every other information which by its nature or circumstances of disclosure may reasonably be regarded as confidential or proprietary, including the subject matter described in Schedule A.
3. Confidentiality Obligations. MYCrave acknowledges that the Confidential Information disclosed by the Client constitutes valuable intellectual property and commercially sensitive information. MYCrave agrees that it shall maintain the strict confidentiality of all Confidential Information received from the Client and shall neither disclose nor communicate such information, directly or indirectly, to any person, entity or organization except as expressly permitted under this Agreement. MYCrave further undertakes that the Confidential Information shall be used exclusively for providing the professional services requested by the Client and for no other purpose whatsoever. MYCrave shall exercise at least the same degree of care in safeguarding the Confidential Information as it exercises for protecting its own confidential information of a similar nature, and in no event shall such degree of care be less than reasonable commercial standards prevailing within the intellectual property profession.
4. Limited Internal Disclosure. The Client acknowledges that, in the ordinary course of rendering professional intellectual property services, it may become necessary for MYCrave to disclose Confidential Information to its directors, patent agents, registered patent attorneys, advocates, technical experts, scientific consultants, researchers, analysts, employees, contract professionals, subject matter experts or affiliated entities strictly on a need-to-know basis. MYCrave represents that every such individual shall either be under contractual confidentiality obligations or shall otherwise be legally bound to preserve the confidentiality of the information to the same extent as required under this Agreement. MYCrave shall remain responsible for ensuring compliance with the confidentiality obligations by every person to whom such information is disclosed.
5. Permitted Disclosure. Notwithstanding anything contained herein, MYCrave shall be entitled to disclose Confidential Information where such disclosure is reasonably necessary for filing, prosecuting or defending intellectual property applications before the Indian Patent Office or any foreign intellectual property office, responding to examination reports, complying with statutory requirements, producing documents before judicial or quasi-judicial authorities, complying with lawful directions issued by governmental or regulatory authorities or where such disclosure is otherwise required by applicable law. Wherever legally permissible, MYCrave shall endeavour to provide prior written notice to the Client before making such disclosure.
6. Exclusions from Confidential Information. The obligations contained in this Agreement shall not apply to information which is demonstrated by documentary evidence to have been publicly available without breach of this Agreement, lawfully known to MYCrave prior to its disclosure by the Client, independently developed by MYCrave without reference to the Client's Confidential Information, lawfully received from a third party having the legal right to disclose such information without restriction, or required to be disclosed pursuant to any applicable law, judicial order or governmental directive.
7. Ownership of Intellectual Property. The Parties expressly acknowledge and agree that every invention, concept, innovation, improvement, patentable idea, industrial design, copyright work, trade secret, technical know-how and all other intellectual property disclosed by the Client shall remain the exclusive property of the Client unless expressly agreed otherwise through a separate written agreement executed by the Parties. Nothing contained in this Agreement shall be construed as assigning, licensing or otherwise transferring any proprietary or intellectual property rights in favour of MYCrave merely by virtue of disclosure or provision of professional services.
8. No Grant of Rights. Nothing contained in this Agreement shall be interpreted as granting MYCrave any express or implied licence, ownership interest, commercial exploitation rights or other intellectual property rights in relation to the Confidential Information disclosed by the Client. MYCrave shall acquire no rights in the Confidential Information except the limited right to use such information solely for providing the services expressly requested by the Client.
9. Return and Retention of Information. Upon completion of the professional engagement or upon receipt of a written request from the Client, MYCrave shall, at the option of the Client, return or securely destroy all Confidential Information and all copies thereof in its possession or control. However, MYCrave shall be entitled to retain archival copies of documents to the extent required for compliance with applicable laws, professional record-keeping obligations, regulatory requirements, insurance purposes, conflict verification procedures or routine electronic backup systems, provided that such retained information shall continue to remain subject to the confidentiality obligations contained herein.
10. Term and Survival. This Agreement shall become effective from the Effective Date and shall continue to remain in force for a period of five (5) years unless terminated earlier by mutual written agreement of the Parties. Notwithstanding such termination or expiry, the obligations relating to unpublished inventions, trade secrets, proprietary technical know-how and all Confidential Information which has not lawfully entered the public domain shall survive until such information becomes publicly available through lawful means.
11. Remedies. The Parties acknowledge that any unauthorized disclosure or misuse of the Confidential Information may cause irreparable injury for which monetary damages alone may not constitute an adequate remedy. Accordingly, the Client shall be entitled to seek injunctive relief, specific performance and any other equitable or legal remedies available under applicable law, in addition to claiming damages, costs and expenses arising from any breach of this Agreement.
12. Governing Law and Dispute Resolution. This Agreement shall be governed by and construed in accordance with the laws of India. Any dispute, controversy or claim arising out of or relating to this Agreement shall first be resolved amicably through mutual discussions between the Parties. In the event that such dispute remains unresolved within thirty (30) days, the same shall be referred to arbitration in accordance with the provisions of the Arbitration and Conciliation Act, 1996, as amended from time to time. The seat and venue of arbitration shall be Vadodara, Gujarat, India, and the proceedings shall be conducted in the English language. Subject to the arbitration provisions, the courts at Vadodara, Gujarat shall have exclusive jurisdiction over matters arising under this Agreement.

This Agreement constitutes the complete understanding between the Parties concerning the confidentiality of the information disclosed and supersedes all prior oral or written communications relating thereto. No amendment, modification or waiver of any provision of this Agreement shall be valid unless made in writing and duly signed by both Parties. If any provision of this Agreement is held to be invalid or unenforceable by a court or tribunal of competent jurisdiction, the remaining provisions shall continue to remain valid and enforceable to the fullest extent permitted by law. This Agreement may be executed in counterparts, including through electronic signatures, each of which shall be deemed an original and together shall constitute one and the same instrument.

Schedule A — the subject matter you describe above.